French pharma giant Sanofi reached a civil settlement with the US Securities and Exchange Commission (SEC) and agreed to pay a multi-million dollar settlement resolving years of bribery inv
The European Commission has approved Sanofi’s Cablivi, the first treatment for patients with the rare blood-clotting disorder, acquired thrombotic thrombocytopenic purpura (aTTP), which is
Fears of border delays and complications in a post-Brexit UK have led to the French pharmaceutical company increasing its contingency stockpiles by four weeks to enable a 14-week supply of